Recent developments in L-asparaginase discovery and its potential as anticancer agent

Area of Science:

• Biochemistry
• Enzymology
• Cancer Therapy

Background:

• L-Asparaginase is a crucial enzyme in treating acute lymphoblastic leukemia (ALL) and other blood cancers.
• It functions by depleting L-asparagine, essential for cancer cell survival, inducing apoptosis.
• Current bacterial L-asparaginase formulations exhibit significant toxicities and lead to treatment resistance.

Purpose of the Study:

• To review the potential of L-asparaginase as an anticancer agent.
• To discuss the mechanism of action and adverse effects of current L-asparaginase treatments.
• To explore alternative sources of L-asparaginase with improved safety profiles.

Main Methods:

• Literature review of L-asparaginase's role in cancer therapy.
• Analysis of current bacterial L-asparaginase formulations and their limitations.
• Investigation into emerging L-asparaginase sources from plants and fungi.

Main Results:

• Bacterial L-asparaginases are effective but associated with toxicities like thrombosis and hyperglycemia.
• Drug resistance is a significant challenge with existing bacterial formulations.
• Plants and fungi represent promising alternative sources for developing less toxic L-asparaginase.

Conclusions:

• L-Asparaginase remains a vital therapeutic enzyme for hematological malignancies.
• Addressing toxicity and resistance necessitates exploring novel L-asparaginase sources.
• Alternative L-asparaginases from non-bacterial origins hold potential for safer and more effective cancer treatment.